OYO parent PRISM flags Zostel dispute as risk in Rs 6,650 crore IPO filing
OYO's parent PRISM filed an updated DRHP for a Rs 6,650 crore fresh-issue IPO, disclosing the ongoing Zostel legal dispute as a business risk that could force transfer of up to 7% shareholding. India accounts for under 12% of gross booking value.
What happened
Oyo · OYO parent PRISM filed updated DRHP for a Rs 6,650 crore fresh-issue IPO, flagging the ongoing Zostel legal dispute as a business risk that could force
Key facts
- Rs 6,650 crore
- 7% stake
- Rs 4,987.5 crore
- 11.9% India GBV
- Rs 2,731.7 crore
- $525 million
Why this matters
The unresolved Zostel litigation flagged in the DRHP is a live acquisition and partnership risk that must be diligenced and ring-fenced before any deal contemplating PRISM's equity.
What to watch
- Court hearings or rulings on the Zostel shareholding claim
- SEBI observations / final approval on updated DRHP
- Anchor book subscription levels and QIB demand signals
- Any revision to fresh-issue size or price band
- Global GBV growth prints validating the sub-12% India narrative
- PRISM/OYO conducts anchor and institutional roadshows emphasizing global GBV mix over India exposure
- Legal counsel provides quantified opinion on Zostel worst-case dilution to bound investor uncertainty
- SEBI review cycle and potential clarificatory addendum to DRHP
- Underwriters calibrate price band to reflect litigation discount
Also reported by
- Medianama — 1h after first sighting